Acarbose treatment in liver disease: cognitive or glycemic control?
Stewart
Charmaine A
CA
Vella
Adrian
A
D020909:Acarbose / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology; D016638:Critical Illness; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000175:diagnosis; D008297:Male; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D020909:Acarbose